<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/794BC5C0-EFD5-43CE-A2CA-95029569098D"><gtr:id>794BC5C0-EFD5-43CE-A2CA-95029569098D</gtr:id><gtr:name>European Association for the Study of the Liver (EASL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F214B81B-2F0A-4723-B5D3-33813C4B47E5"><gtr:id>F214B81B-2F0A-4723-B5D3-33813C4B47E5</gtr:id><gtr:name>John Radcliffe Hospital</gtr:name><gtr:address><gtr:line1>Headley Way</gtr:line1><gtr:line2>Headington</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 9DU</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Cellular Medicine</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/794BC5C0-EFD5-43CE-A2CA-95029569098D"><gtr:id>794BC5C0-EFD5-43CE-A2CA-95029569098D</gtr:id><gtr:name>European Association for the Study of the Liver (EASL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F214B81B-2F0A-4723-B5D3-33813C4B47E5"><gtr:id>F214B81B-2F0A-4723-B5D3-33813C4B47E5</gtr:id><gtr:name>John Radcliffe Hospital</gtr:name><gtr:address><gtr:line1>Headley Way</gtr:line1><gtr:line2>Headington</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 9DU</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/AE7EA01F-0FBC-454A-9BBC-762E455AC90B"><gtr:id>AE7EA01F-0FBC-454A-9BBC-762E455AC90B</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Emrys</gtr:otherNames><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/01AF5C3D-E9B4-4F46-959C-D6B15590667F"><gtr:id>01AF5C3D-E9B4-4F46-959C-D6B15590667F</gtr:id><gtr:firstName>Julia</gtr:firstName><gtr:surname>Newton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4CF6F3AD-BC9B-4AA3-8076-E4A86D1410BE"><gtr:id>4CF6F3AD-BC9B-4AA3-8076-E4A86D1410BE</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Bamforth</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9AE10A78-7CDF-4F29-9B1F-D0EE2281101D"><gtr:id>9AE10A78-7CDF-4F29-9B1F-D0EE2281101D</gtr:id><gtr:firstName>Roy</gtr:firstName><gtr:surname>Taylor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0500020"><gtr:id>EAC1961B-B1ED-4D6B-9BA3-9B3DCBC918D5</gtr:id><gtr:title>Pathogenetic Mechanism and Potential Therapeutic Targets for Fatigue in Primary Biliary Cirrhosis (PBC)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500020</gtr:grantReference><gtr:abstractText>The chronic liver disease primary biliary cirrhosis (PBC), which affects up to 20,000 patients in the UK, is characterised by profound, often life-altering, fatigue. At present we neither understand why PBC patients get fatigue nor have any effective treatments for that fatigue. The aim of this project is to explore the mechanisms which are responsible for fatigue in PBC in order to identify potential new avenues for treatment. We intend to use new technologies to study brain function, peripheral muscle function (including the effectiveness of muscle when undertaking exercise) and the function of the autonomic system (the part of the nervous system that prepares the body for every-day function including exercise). Fatigue is a difficult symptom for patients, and one that generates much controversy. This study is unique in that it systematically studies a series of potential aetiological factors in the same patients, whilst including a control group of patients who suffer from the same underlying condition, but who do not experience the symptom. The ability to diagnose the disease in the absence of the symptom provides unique opportunities in the study of fatigue which are not available in conditions, such as chronic fatigue syndrome, where the presence of the symptom is required for disease diagnosis. PBC could therefore potentially represent a useful human model for the study of fatigue.</gtr:abstractText><gtr:technicalSummary>Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease characterised by profound fatigue which significantly reduces health-related quality of life (HRQOL) and which is currently untreatable. Our pilot studies have identified brain stem deposition of manganese, autonomic dysfunction (including loss of baroreflex sensitivity), suppression of the HPA axis, and reduced sustainability of skeletal muscle function as being features associated with the presence of fatigue in PBC patients. Moreover, prospective studies have suggested an increased mortality rate in fatigued PBC patients, principally resulting from an excess of sudden cardiac deaths. It is our hypothesis that CNS changes occur in response to cholestasis (or the inflammatory processes giving rise to cholestasis). The consequences of these CNS events include HPA suppression and autonomic dysfunction which have a net effect on perfusion and energy utilisation peripherally in muscle. In skeletal muscle this effect manifests itself as fatiguability and the sensation of fatigue, whilst in cardiac muscle it manifests itself as instability and a pre-disposition to sudden cardiac events. In the first phase of the study we will characterise the impact of fatigue on HRQOL on the whole North-Eastern UK PBC population (amongst the worlds largest and best characterised cohorts). This study will allow us to define high and low fatigue states and to identify appropriate subjects for the second phase of the study in which we will perform a comprehensive series of linked, innovative studies to address the biological basis of fatigue. MRI-based approaches will be used to characterise the CNS changes associated with fatigue and to directly study the bioenergetics of both skeletal and cardiac muscle. ?Upstream? CNS changes and ?downstream? muscle bioenergetic changes will be cross-correlated with comprehensive studies of autonomic function and of the HPA axis, including novel studies of the effects of 5HT releasing agents on this system imaged using an innovative MRI based approach developed for the project (abnormality of the hippocampal 5HT system has been strongly implicated in behavioural changes seen in cholestatic animal models). Comparison between otherwise matched fatigued and non-fatigued patients will allow us to develop a ?map? of the physiological changes associated with fatigue in PBC. Linear studies performed in patients listed for transplantation will also allow us to assess the reversibility of these changes post-transplant. These studies will provide a comprehensive and unique insight into the pathogenesis of fatigue, one of the most challenging problems faced by PBC patients and their carers.</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>198422</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Association for the Study of the Liver (EASL)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>EASL Clinical Practice Guidelines Group for Cholestatic Liver Disease</gtr:description><gtr:id>6419035E-7C7F-4350-A7F0-0AFF6E61BA3A</gtr:id><gtr:impact>Published clinical guidelines PubMed ID: 19501929</gtr:impact><gtr:partnerContribution>Establishment of clinical treatment paradigms for fatigue in PBC</gtr:partnerContribution><gtr:piContribution>Provided original data to inform the development of relevant clinical guidelines</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>John Radcliffe Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Gastroenterology</gtr:department><gtr:description>UK-PBC Research Consortium</gtr:description><gtr:id>06EF1F90-3158-492D-9730-24E9847E5FFA</gtr:id><gtr:impact>Two Nature Genetics publications 
Manuscript in re-submission to Gastroenterology</gtr:impact><gtr:partnerContribution>Recrutiment to studyPatient recruitmentPatient recruitmentPatient recruitment</gtr:partnerContribution><gtr:piContribution>The UK PBC research community has come together over the last 4 years in order to facilitate large-scale studies in PBC (www.UK-PBC.com). The first such study was a GWAS funded under Wellcome Trust WTCCC3 which recruited 5000 patients and which has published its results in 2 Nature Genetics papers. The next consortium project was to use the unique UK-PBC patient database to explore critical clinical questions in PBC. This work has highlighted the unmet clinical need in PBC in relation to failure of response to primary therapy with ursodeoxycholic acid (UDCA). The strength of the data (the UK-PBC cohort study which was presented at the American Association for the Study of Liver Diseases (AASLD) in 2012 and which is in re-submission to the field leading journal Gastroenterology) has informed a forthcoming submission to the MRC Stratified Medicine call and has attracted significant industry interest in PBC in general and in the UK as a location in which to undertake therapeutics work in PBC in particular. I am the Chief Investigator for UK-PBC and for the forthcoming MRC Stratified Medicine bid</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals Birmingham NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Queen Elizabeth Medical Centre, Birmingham</gtr:department><gtr:description>UK-PBC Research Consortium</gtr:description><gtr:id>7D987749-C3D3-4EE7-B833-789AC37AEF48</gtr:id><gtr:impact>Two Nature Genetics publications 
Manuscript in re-submission to Gastroenterology</gtr:impact><gtr:partnerContribution>Recrutiment to studyPatient recruitmentPatient recruitmentPatient recruitment</gtr:partnerContribution><gtr:piContribution>The UK PBC research community has come together over the last 4 years in order to facilitate large-scale studies in PBC (www.UK-PBC.com). The first such study was a GWAS funded under Wellcome Trust WTCCC3 which recruited 5000 patients and which has published its results in 2 Nature Genetics papers. The next consortium project was to use the unique UK-PBC patient database to explore critical clinical questions in PBC. This work has highlighted the unmet clinical need in PBC in relation to failure of response to primary therapy with ursodeoxycholic acid (UDCA). The strength of the data (the UK-PBC cohort study which was presented at the American Association for the Study of Liver Diseases (AASLD) in 2012 and which is in re-submission to the field leading journal Gastroenterology) has informed a forthcoming submission to the MRC Stratified Medicine call and has attracted significant industry interest in PBC in general and in the UK as a location in which to undertake therapeutics work in PBC in particular. I am the Chief Investigator for UK-PBC and for the forthcoming MRC Stratified Medicine bid</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine KCL</gtr:department><gtr:description>UK-PBC Research Consortium</gtr:description><gtr:id>B5A4DEDE-A785-47F9-8EE6-321888776298</gtr:id><gtr:impact>Two Nature Genetics publications 
Manuscript in re-submission to Gastroenterology</gtr:impact><gtr:partnerContribution>Recrutiment to studyPatient recruitmentPatient recruitmentPatient recruitment</gtr:partnerContribution><gtr:piContribution>The UK PBC research community has come together over the last 4 years in order to facilitate large-scale studies in PBC (www.UK-PBC.com). The first such study was a GWAS funded under Wellcome Trust WTCCC3 which recruited 5000 patients and which has published its results in 2 Nature Genetics papers. The next consortium project was to use the unique UK-PBC patient database to explore critical clinical questions in PBC. This work has highlighted the unmet clinical need in PBC in relation to failure of response to primary therapy with ursodeoxycholic acid (UDCA). The strength of the data (the UK-PBC cohort study which was presented at the American Association for the Study of Liver Diseases (AASLD) in 2012 and which is in re-submission to the field leading journal Gastroenterology) has informed a forthcoming submission to the MRC Stratified Medicine call and has attracted significant industry interest in PBC in general and in the UK as a location in which to undertake therapeutics work in PBC in particular. I am the Chief Investigator for UK-PBC and for the forthcoming MRC Stratified Medicine bid</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>UK-PBC Research Consortium</gtr:description><gtr:id>5A16F857-7D30-4E62-8B6F-2566A8F9B9DF</gtr:id><gtr:impact>Two Nature Genetics publications 
Manuscript in re-submission to Gastroenterology</gtr:impact><gtr:partnerContribution>Recrutiment to studyPatient recruitmentPatient recruitmentPatient recruitment</gtr:partnerContribution><gtr:piContribution>The UK PBC research community has come together over the last 4 years in order to facilitate large-scale studies in PBC (www.UK-PBC.com). The first such study was a GWAS funded under Wellcome Trust WTCCC3 which recruited 5000 patients and which has published its results in 2 Nature Genetics papers. The next consortium project was to use the unique UK-PBC patient database to explore critical clinical questions in PBC. This work has highlighted the unmet clinical need in PBC in relation to failure of response to primary therapy with ursodeoxycholic acid (UDCA). The strength of the data (the UK-PBC cohort study which was presented at the American Association for the Study of Liver Diseases (AASLD) in 2012 and which is in re-submission to the field leading journal Gastroenterology) has informed a forthcoming submission to the MRC Stratified Medicine call and has attracted significant industry interest in PBC in general and in the UK as a location in which to undertake therapeutics work in PBC in particular. I am the Chief Investigator for UK-PBC and for the forthcoming MRC Stratified Medicine bid</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Patient information leaflet &amp; DVD</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1246FCB7-35BF-497B-9BEE-2B2C2F1875C8</gtr:id><gtr:impact>Our findings have informed new patient information media (conventional leaflets and a novel DVD) which explain &amp;quot;self-help&amp;quot; approaches to fatigue in PBC informed by our study. A paper describing the development and value to patients of this DVD has been accepted for publicatuion.

Highlighted by patient web fora internationally</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Care Pathway</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1A921F4A-5284-439C-8FBF-04D76BF70520</gtr:id><gtr:impact>The studies funded by this grant have informed the design of the fatigue/cognitive component of a novel integrated are pathway for PBC published in QJM (2008; 101:535-543) and in the National Library for Health http://www.library.nhs.uk/Pathways/SearchResults.aspx?searchText=cirrhosis&amp;amp;tabID=288 In our experience implementation of this pathway across a whole clinical service is associated with a significant overall improvement in patient quality of life (QJM as above).

Entering wide clinical use in the field</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.library.nhs.uk/Pathways/SearchResults.aspx?searchText=cirrhosis&amp;tabID=288</gtr:url><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Group Meetings</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BE1717E4-BED7-4BC2-9690-23F0FE3EBC45</gtr:id><gtr:impact>PBC patient research update meetings. These are held around the region 6 times per year to explain our research, the rationale behind it, the key findings and what this means and may mean for the future improvements in treatment

In addition to their intrinsic worth these meetings hold substantial benefits in terms of recruitment rates for our studies.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2009,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>132000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ME Research UK funding</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>ME Research UK</gtr:fundingOrg><gtr:id>B292CA74-A446-4F22-A1B8-F2F70E5B1CAF</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CFS Research Call</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D106F9F5-BBA6-4AF2-8639-78436B2A3B10</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4972138</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Stratified Medicine</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L001489/1</gtr:fundingRef><gtr:id>460C4D96-82CB-4C58-84B0-15273D91CD61</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Efficacy and Mechanism Evaluation (EME) Programme</gtr:department><gtr:description>EME</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A765A25B-08B7-4FF7-81E8-A8BDE8009BC3</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European Treatment Guidelines</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>B7A61F45-61D6-4B66-8EC5-38EDD0F27D2B</gtr:id><gtr:impact>I am a member of the European Association for the Study of the Liver (EASL) guideline for cholestatic liver disease (including PBC). These guidelines, which will be published shortly were informed in relation to fatigue management by my work ; First clinical guideline for PBC which acknowledges the importance of fatigue in the liver of patients and addresses its treatment</gtr:impact><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contribution to education</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>3753531B-ACBC-415D-9AEA-E5789E82EDAF</gtr:id><gtr:impact>Appreciation of fatigue as a clinical problem, and target for treatment in its own right, in PBC ; Transformed the nature of the clinical problems associated with fatigue</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Integrated care pathway for the management of PBC</gtr:description><gtr:id>EFC23532-C657-4698-8338-8D3C9435FA7A</gtr:id><gtr:impact>This pathway allows the systematisation of the management of PBC and, critically, access to the optimal approach to management (including with a focus on symptom management and quality of life optimisation) to all patients regardless of whether they have access to a specialist clinic</gtr:impact><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Closed</gtr:status><gtr:title>Integrated care pathway for PBC</gtr:title><gtr:type>Management of Diseases and Conditions</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Development of a new assessment protocol and exercise performance rig suitable for use in an MR scanner</gtr:description><gtr:id>CB958AAA-36D0-43BB-93CD-0DC9A2E577FD</gtr:id><gtr:impact>Published protocol for new technique allows standardisation of the approach</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>fMRI Assessment Protocol for Peripheral Muscle Function</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Comprehensive database of the largest cohort of patients with PBC in the world, uniquely linking conventional data relating to disease severity and pathogenesis with symptom severity data (obtained using a novel disease- specific quality of life measure developed by my group (non-MRC funded)) and symptom aetiological process data</gtr:description><gtr:id>AAAD7E84-2271-4646-B426-670AA5B2204C</gtr:id><gtr:impact>This tool proved that fatigue was not simply a consequence of conventional disease progression processes but is associated with distinct additional processes. The comprehensive nature of the dataset allowed novel links to be made (between, for example, fatigue and overt cognitive impairment) and an association between high symptom load and increased death rate to be made.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PBC Clinical Cohort Database</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Our successful development of symptom management algorhythms in liver disease have informed grant applications to develop a similar approach in other chronic diseases</gtr:description><gtr:id>892A1A08-FF43-4DED-8BFC-75B0B2451CC4</gtr:id><gtr:impact>Grant applications in early renal disease to RfPB, thyroid disease to the Action Medical Research, Sjogrens to ARC. All utilise the methodologies developed in the MRC funded study.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Fatigue Management Algorythm</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/62838AF9-F4A1-485A-9A57-863B715D1186"><gtr:id>62838AF9-F4A1-485A-9A57-863B715D1186</gtr:id><gtr:title>Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/43874f3c2c95d6884cbceb8d6ce4445a"><gtr:id>43874f3c2c95d6884cbceb8d6ce4445a</gtr:id><gtr:otherNames>Newton JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E636B86-7693-4EE8-8209-3FC60E9691A1"><gtr:id>2E636B86-7693-4EE8-8209-3FC60E9691A1</gtr:id><gtr:title>Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study.</gtr:title><gtr:parentPublicationTitle>European journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0624396d5239dd81c84ef38c5d6c9399"><gtr:id>0624396d5239dd81c84ef38c5d6c9399</gtr:id><gtr:otherNames>Jones DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2972</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC812955-FBEB-49EC-BD29-A16C49981C12"><gtr:id>FC812955-FBEB-49EC-BD29-A16C49981C12</gtr:id><gtr:title>Falls and fall-related injury are common in older people with chronic liver disease.</gtr:title><gtr:parentPublicationTitle>Digestive diseases and sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/afa82016345f415704bcfe5850a2f651"><gtr:id>afa82016345f415704bcfe5850a2f651</gtr:id><gtr:otherNames>Frith J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0163-2116</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7222497E-A6D2-4555-B4B3-664124D7037E"><gtr:id>7222497E-A6D2-4555-B4B3-664124D7037E</gtr:id><gtr:title>The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9 year follow-up.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0624396d5239dd81c84ef38c5d6c9399"><gtr:id>0624396d5239dd81c84ef38c5d6c9399</gtr:id><gtr:otherNames>Jones DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F229340-E14F-419C-A780-122A7380E123"><gtr:id>9F229340-E14F-419C-A780-122A7380E123</gtr:id><gtr:title>Functional capacity is significantly impaired in primary biliary cirrhosis and is related to orthostatic symptoms.</gtr:title><gtr:parentPublicationTitle>European journal of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/43874f3c2c95d6884cbceb8d6ce4445a"><gtr:id>43874f3c2c95d6884cbceb8d6ce4445a</gtr:id><gtr:otherNames>Newton JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0954-691X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF57CD19-6BD4-46F3-9D61-E54F3DFF834A"><gtr:id>EF57CD19-6BD4-46F3-9D61-E54F3DFF834A</gtr:id><gtr:title>Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/43874f3c2c95d6884cbceb8d6ce4445a"><gtr:id>43874f3c2c95d6884cbceb8d6ce4445a</gtr:id><gtr:otherNames>Newton JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2332E160-A19B-41A0-98BB-E060210CE3D0"><gtr:id>2332E160-A19B-41A0-98BB-E060210CE3D0</gtr:id><gtr:title>Cognitive impairment in non-cirrhotic chronic liver disease is unrelated to liver disease severity but associated with ineffective baroreflex function.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/afa82016345f415704bcfe5850a2f651"><gtr:id>afa82016345f415704bcfe5850a2f651</gtr:id><gtr:otherNames>Frith J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/009AACD0-EA79-4153-AE92-02610E5936A1"><gtr:id>009AACD0-EA79-4153-AE92-02610E5936A1</gtr:id><gtr:title>Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1082243-4D00-4F14-B444-BF25981D2D62"><gtr:id>A1082243-4D00-4F14-B444-BF25981D2D62</gtr:id><gtr:title>Anti-oxidants do not prevent bile acid-induced cell death in rat hepatocytes.</gtr:title><gtr:parentPublicationTitle>Liver international : official journal of the International Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/84c97bc3b1afd11d1cb9ef1b6c8d9b2c"><gtr:id>84c97bc3b1afd11d1cb9ef1b6c8d9b2c</gtr:id><gtr:otherNames>Bhogal RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1478-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/710A5361-3E80-4ED6-891E-71B4DEFD2628"><gtr:id>710A5361-3E80-4ED6-891E-71B4DEFD2628</gtr:id><gtr:title>Managing systemic symptoms in chronic liver disease.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/43874f3c2c95d6884cbceb8d6ce4445a"><gtr:id>43874f3c2c95d6884cbceb8d6ce4445a</gtr:id><gtr:otherNames>Newton JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A4430E32-EF56-4AD4-AB30-C032C13BB0F8"><gtr:id>A4430E32-EF56-4AD4-AB30-C032C13BB0F8</gtr:id><gtr:title>Fatigue in primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/67a992aae3dd38f4eeca58b3be6e4720"><gtr:id>67a992aae3dd38f4eeca58b3be6e4720</gtr:id><gtr:otherNames>Hale M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FCE3E40E-B230-4521-9A3E-55E295A4BC58"><gtr:id>FCE3E40E-B230-4521-9A3E-55E295A4BC58</gtr:id><gtr:title>Cardiac torsion-strain relationships in fatigued primary biliary cirrhosis patients show accelerated aging: a pilot cross-sectional study.</gtr:title><gtr:parentPublicationTitle>Journal of applied physiology (Bethesda, Md. : 1985)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdf878e42a37a7f62b5e7575b0a3a6e7"><gtr:id>bdf878e42a37a7f62b5e7575b0a3a6e7</gtr:id><gtr:otherNames>Hollingsworth KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0161-7567</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB5EAD0A-A91C-4697-B051-748C52C5AC46"><gtr:id>DB5EAD0A-A91C-4697-B051-748C52C5AC46</gtr:id><gtr:title>An integrated care pathway improves quality of life in Primary Biliary Cirrhosis.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0624396d5239dd81c84ef38c5d6c9399"><gtr:id>0624396d5239dd81c84ef38c5d6c9399</gtr:id><gtr:otherNames>Jones DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7E5DDD95-6AAE-4363-8865-2BD994127B0F"><gtr:id>7E5DDD95-6AAE-4363-8865-2BD994127B0F</gtr:id><gtr:title>Impaired cerebral autoregulation in primary biliary cirrhosis: implications for the pathogenesis of cognitive decline.</gtr:title><gtr:parentPublicationTitle>Liver international : official journal of the International Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdf878e42a37a7f62b5e7575b0a3a6e7"><gtr:id>bdf878e42a37a7f62b5e7575b0a3a6e7</gtr:id><gtr:otherNames>Hollingsworth KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1478-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/523FC33D-497A-45AE-AA22-76E4D3880C01"><gtr:id>523FC33D-497A-45AE-AA22-76E4D3880C01</gtr:id><gtr:title>Perceived fatigue is comparable between different disease groups.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0624396d5239dd81c84ef38c5d6c9399"><gtr:id>0624396d5239dd81c84ef38c5d6c9399</gtr:id><gtr:otherNames>Jones DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/55484567-00D1-4903-8983-972995C7831E"><gtr:id>55484567-00D1-4903-8983-972995C7831E</gtr:id><gtr:title>EASL Clinical Practice Guidelines: management of cholestatic liver diseases.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1b48e0c05a6c0eb72e0edf1a1e38199d"><gtr:id>1b48e0c05a6c0eb72e0edf1a1e38199d</gtr:id><gtr:otherNames>European Association for the Study of the Liver</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9B0509B5-9BC1-4D98-BDDE-B0862DE05AF8"><gtr:id>9B0509B5-9BC1-4D98-BDDE-B0862DE05AF8</gtr:id><gtr:title>Restless leg syndrome is a treatable cause of sleep disturbance and fatigue in primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>Liver international : official journal of the International Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f374dcc13f3009fa41c40d7ef5f0f208"><gtr:id>f374dcc13f3009fa41c40d7ef5f0f208</gtr:id><gtr:otherNames>Anderson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1478-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3F08623-DA25-4AD7-A597-706A5076E869"><gtr:id>E3F08623-DA25-4AD7-A597-706A5076E869</gtr:id><gtr:title>Reduced thoracic fluid content in early-stage primary biliary cirrhosis that associates with impaired cardiac inotropy.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/156ee9ababc3765b6580f7febf49bb68"><gtr:id>156ee9ababc3765b6580f7febf49bb68</gtr:id><gtr:otherNames>Zalewski P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DAA2BC53-ED81-4539-B417-2872DFD60BE7"><gtr:id>DAA2BC53-ED81-4539-B417-2872DFD60BE7</gtr:id><gtr:title>Variability of perceived fatigue in primary biliary cirrhosis: implications for symptom assessment.</gtr:title><gtr:parentPublicationTitle>Liver international : official journal of the International Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b6ad6f1fcdfbb25da8cb6f4924f925e5"><gtr:id>b6ad6f1fcdfbb25da8cb6f4924f925e5</gtr:id><gtr:otherNames>Newton J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1478-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BF568C2F-006F-459E-97D8-C9553C1B645E"><gtr:id>BF568C2F-006F-459E-97D8-C9553C1B645E</gtr:id><gtr:title>Impaired cardiovascular function in primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0624396d5239dd81c84ef38c5d6c9399"><gtr:id>0624396d5239dd81c84ef38c5d6c9399</gtr:id><gtr:otherNames>Jones DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8207419C-24E5-4E23-92B1-DCC3559A4E3A"><gtr:id>8207419C-24E5-4E23-92B1-DCC3559A4E3A</gtr:id><gtr:title>A predictive model for fatigue and its etiologic associations in primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/43874f3c2c95d6884cbceb8d6ce4445a"><gtr:id>43874f3c2c95d6884cbceb8d6ce4445a</gtr:id><gtr:otherNames>Newton JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1542-3565</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/51015F32-A12E-402E-980B-E565792B5D40"><gtr:id>51015F32-A12E-402E-980B-E565792B5D40</gtr:id><gtr:title>Loss of capacity to recover from acidosis in repeat exercise is strongly associated with fatigue in primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdf878e42a37a7f62b5e7575b0a3a6e7"><gtr:id>bdf878e42a37a7f62b5e7575b0a3a6e7</gtr:id><gtr:otherNames>Hollingsworth KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7E34A4E-CCD4-4F22-919F-410104BDDFD0"><gtr:id>D7E34A4E-CCD4-4F22-919F-410104BDDFD0</gtr:id><gtr:title>Globus pallidus magnetization transfer ratio, T(1) and T(2) in primary biliary cirrhosis: relationship with disease stage and age.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdf878e42a37a7f62b5e7575b0a3a6e7"><gtr:id>bdf878e42a37a7f62b5e7575b0a3a6e7</gtr:id><gtr:otherNames>Hollingsworth KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37CFB469-E01B-4EAC-BB61-4F1F1E157668"><gtr:id>37CFB469-E01B-4EAC-BB61-4F1F1E157668</gtr:id><gtr:title>Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/41e21049ed36ea2a66f7459fa8c75155"><gtr:id>41e21049ed36ea2a66f7459fa8c75155</gtr:id><gtr:otherNames>Mells GF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/015E1115-770C-4F66-B37F-901022D80E50"><gtr:id>015E1115-770C-4F66-B37F-901022D80E50</gtr:id><gtr:title>Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2cac655be20e91b42129ffc0b189756"><gtr:id>e2cac655be20e91b42129ffc0b189756</gtr:id><gtr:otherNames>McDonald C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/81180F3F-59E2-4161-9258-8518A922DB1C"><gtr:id>81180F3F-59E2-4161-9258-8518A922DB1C</gtr:id><gtr:title>Serum anti-mitochondrial antibodies and fatigue in primary biliary cirrhosis.</gtr:title><gtr:parentPublicationTitle>Liver international : official journal of the International Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b6ad6f1fcdfbb25da8cb6f4924f925e5"><gtr:id>b6ad6f1fcdfbb25da8cb6f4924f925e5</gtr:id><gtr:otherNames>Newton J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1478-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B562A8A9-0501-4A0C-AD07-8B994AA16EB5"><gtr:id>B562A8A9-0501-4A0C-AD07-8B994AA16EB5</gtr:id><gtr:title>Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/afa82016345f415704bcfe5850a2f651"><gtr:id>afa82016345f415704bcfe5850a2f651</gtr:id><gtr:otherNames>Frith J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0DEC6614-DB71-4817-B4EE-0F97B352C988"><gtr:id>0DEC6614-DB71-4817-B4EE-0F97B352C988</gtr:id><gtr:title>Reduction in functional ability is significant postliver transplantation compared with matched liver disease and community dwelling controls.</gtr:title><gtr:parentPublicationTitle>Transplant international : official journal of the European Society for Organ Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1a4dfdc62ba80bc2551f27b2ebc26706"><gtr:id>1a4dfdc62ba80bc2551f27b2ebc26706</gtr:id><gtr:otherNames>Elliott C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0934-0874</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1AA7390A-08D7-4780-8743-80C9142A5DC3"><gtr:id>1AA7390A-08D7-4780-8743-80C9142A5DC3</gtr:id><gtr:title>Primary biliary cirrhosis is associated with falls and significant fall related injury.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/afa82016345f415704bcfe5850a2f651"><gtr:id>afa82016345f415704bcfe5850a2f651</gtr:id><gtr:otherNames>Frith J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/951AEA24-1DEF-4FC9-AF8A-63F827B0A426"><gtr:id>951AEA24-1DEF-4FC9-AF8A-63F827B0A426</gtr:id><gtr:title>Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis.</gtr:title><gtr:parentPublicationTitle>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdf878e42a37a7f62b5e7575b0a3a6e7"><gtr:id>bdf878e42a37a7f62b5e7575b0a3a6e7</gtr:id><gtr:otherNames>Hollingsworth KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1542-3565</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500020</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>